Of note, the frequency of DSG2+ tumors observed in this analysis using the 10G11 mAb was very similar to the results obtained in Figure 2A using the 6D8 mAb, providing independent validation of the proportion of human melanomas that express DSG2. The gene discussed is DSG2; the disease is melanoma.